In this issue:
- 9-month delamanid-linezolid-levofloxacin-pyrazinamide for MDR-TB
- Two short standardised regimens for rifampicin-resistant TB
- Nonadherence and regimen shortening in drug-sensitive TB
- High-dose rifamycin for TB
- Sex differences for TB patients in India
- Aerosolisation of M. tuberculosis by tidal breathing
- Response to hypoxia and inflammation dysregulation impacts M. tuberculosis pathogenicity
- Long-term impact of early-life TB
- Presumed nondiagnosed TB in sub-Saharan Africa
- Latent TB infection among Waikato Māori
- 6-week regimen for treating latent TB
- Deep learning model for nontuberculous mycobacterial pulmonary disease
Please login below to download this issue (PDF)